Merck & Co Inc

Healthcare
$105.50
-0.18 (0.17%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$103.70$105.68297,4648,399,920

Fundamentals

Market Cap$267.94B
P/B Ratio6
P/E Ratio17.6
Enterprise Value$287.21B
Div. Yield2.76%
Book Value17.54
EPS(TTM)6.03
ROE36.60%
Understand Fundamentals

About the Company

Merck & Co. is an American-based multinational pharmaceutical company headquartered in Kenilworth, New Jersey. On Jan 2, 1970, Merck & Co. began trading on NYSE and NASDAQ under the symbol of ‘’MRK’’. Merck & Co. shares are enlisted in the DJIA, S&P 100, and S&P 500 indexes. As of 2019, this company holds an employee base of above 70000. Merck & Co.’s operations are segregated into four domains, namely Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck & Co., Inc focuses on Oncology, Infectious diseases, vaccines, Cardio-metabolic disorders, and inventions and developments. Products offered under its Pharmaceutical segment includes Arcoxia, Clarinex, Januvia, and Janumet. The Animal Health segment of Merck & Co.’s invents, develops, produces, and promotes animal health products as well as vaccines. Its Consumer healthcare segment develops, produces, and advertises OTC products, sun care and foot care products. The legacy products of this company include the first mumps vaccine and the first rubella vaccine. It’s also partnered with AstraZeneca LP for the sales of Nexium and Prilosec. This company started its journey as an independent American company from 1917. In the United States and Canada, the company continued to function under its initial name and elsewhere it is referred to as Merck Sharp & Dohme (MSD). Merck & Co., Inc was incorporated in New Jersey in 1970. Merck & Co. is associated with various philanthropic activities. It is the first American pharmaceutical company to provide a Patient Assistance program to individuals incapable of purchasing medicines. The company had also initiated the first commercial manufacturing of morphine. Merck & Co. has acquired over 20 companies since its inception. Among those, 12 of them occurred in the last five years. Its acquisition of the Philadelphia-based Sharp & Dohme in 1953 made the company the largest US drug manufacturer. Of all the acquisition to date, the largest was when it bought off its competitor, Schering-Plough for $41.1 billion in 2009. Another significant acquisition of Merck & Co. includes Idenix Pharmaceuticals for nearly $3.85 billion. It sold Merial to Sanofi SA in 2009 for $4 billion. The year 2020 has earned Merck & Co. several awards. The company held 4th position in two categories, including Best Employees for New Grads 2020 and America’s Best Employers By State 2020. Also, it ranked 92nd in Forbes’ Global 2000 2020 list. The company ranked 69th on the list of Fortune 500 companies 2020 as well.;
OrganisationMerck & Co Inc
IndustryDrug Manufacturers—General
HeadQuartersKenilworth, NJ

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Want to invest in US Stocks?
Signup with Groww to get started
Login / Register
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI